In line, morbidly obese patients with NASH have higher intrahepatic gene expression of Th1-associated genes and a decreased ratio of IL-10/IFNy as compared to patients with non-alcoholic fatty liver disease (38). Here, NELFCD is linked to metabolic dysfunction-associated steatohepatitis.